$MNST

1 thesis
bullish 0%neutral 100%bearish 0%
Avg return (1m)
—
Win rate (1m)
— (0 resolved)

Past performance does not predict future results. Informational only, not investment advice.

Recent theses

$MNSTr/ValueInvestingStock Analysisneutral
u/dermsen · 10h ago5 prior · awaiting results

The "safe" names are priced for 1.6 to 5.4 times their revenue growth.

Monster is priced for 20.2% annual FCF growth, but recent TTM revenue growth of 20.2% already matches that requirement. The valuation hinges on whether the last twelve months represent a sustainable pace rather than a temporary spike.

original post →

End of results.